Blood-based biomarkers predicting response to antidepressants
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impaired glucocorticoid receptor (GR) function seems to be one reason for this dysregulation (Busch and Menke 2019; Mokhtari et al. 2013; Silverman and Sternberg 2012).”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Busch and Menke 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
A functional polymorphism in the monoamine oxidase A gene promoter
Sabol, S. Z., Hu, S., & Hamer, D. (1998) · Human Genetics · doi:10.1007/s004390050816 · Cited by 1,079
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Research works printed but not linked: 133
- Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L (2006) Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord 90(2–3):251–256 (PubMed PMID: 16356553) · DOI
- Arias B, Fabbri C, Gressier F, Serretti A, Mitjans M, Gasto C et al (2013) TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. Neuropsychobiology 67(1):41–47 (PubMed PMID: 23221997, Epub 2012/12/12.eng) · DOI
- Aschbacher K, Mills PJ, von Kanel R, Hong S, Mausbach BT, Roepke SK et al (2008) Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 22(4):493–502 (PubMed PMID: 18054198, Pubmed Central PMCID: 2442159) · DOI
- Baffa A, Hohoff C, Baune BT, Muller-Tidow C, Tidow N, Freitag C et al (2010) Norepinephrine and serotonin transporter genes: impact on treatment response in depression. Neuropsychobiology 62(2):121–131 (PubMed PMID: 20588071) · DOI · Paper page
- Barron E, Lara J, White M, Mathers JC (2015) Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PloS One 10(6):e0127550 (PubMed PMID: 26039142, Pubmed Central PMCID: 4454670) · DOI · Paper page
- Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K (2008) Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 436(2):111–115 (PubMed PMID: 18387740, Epub 2008/04/05.eng) · DOI
- Baune BT, Dannlowski U, Domschke K, Janssen DG, Jordan MA, Ohrmann P et al (2010) The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67(6):543–549 (PubMed PMID: 20044070, Epub 2010/01/02.eng) · DOI · Paper page
- Bleys D, Luyten P, Soenens B, Claes S (2018) Gene–environment interactions between stress and 5-HTTLPR in depression: a meta-analytic update. J Affect Disord 15(226):339–345 (PubMed PMID: 29031184) · DOI
- Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C et al (2000) Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am J Med Genet 96(6):831–835 (PubMed PMID: 11121191) · DOI · Paper page
- Bortolozzi A, Castane A, Semakova J, Santana N, Alvarado G, Cortes R et al (2012) Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry 17(6):612–623 (PubMed PMID: 21808255, Epub 2011/08/03.eng) · DOI
- Bozina N, Peles AM, Sagud M, Bilusic H, Jakovljevic M (2008) Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder. World J Biol Psychiatry 9(3):190–197 (PubMed PMID: 17853254, Epub 2007/09/14.eng) · DOI · Paper page
- Breitenstein B, Bruckl TM, Ising M, Muller-Myhsok B, Holsboer F, Czamara D (2015) ABCB1 gene variants and antidepressant treatment outcome: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 168B(4):274–283 (PubMed PMID: 25847751) · DOI · Paper page
- Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L (2009) Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 119(1–3):107–115 (PubMed PMID: 19339052, Epub 2009/04/03.eng) · DOI
- Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389 (PubMed PMID: 12869766) · DOI · Paper page
- Cattaneo A, Pariante CM (2018) Integrating ‘Omics’ approaches to prioritize new pathogenetic mechanisms for mental disorders. Neuropsychopharmacology 43(1):227–228 (PubMed PMID: 29192656, Pubmed Central PMCID: PMC5719117) · DOI
- Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA, Gennarelli M (2010a) The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 35(7):1423–1428 (PubMed PMID: 20164831, Pubmed Central PMCID: PMC3055467, Epub 2010/02/19.eng) · DOI
- Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M (2010b) Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol 13(1):103–108 (PubMed PMID: 19835669, Epub 2009/10/20.eng) · DOI · Paper page
- Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158(5):748–753 (PubMed PMID: 11329397, Epub 2001/05/01.eng) · DOI · Paper page
- Crissman AM, Makhay MM, O’Donnell JM (2001) Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors. Psychopharmacology 154(1):70–75 (PubMed PMID: 11292008, Epub 2001/04/09.eng) · DOI
- Crowley JJ, Lipsky RH, Lucki I, Berrettini WH (2008) Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome. Psychiatr Genet 18(5):248–251 (PubMed PMID: 18797399, Epub 2008/09/18.eng) · DOI
- Culverhouse RC, Saccone NL, Horton AC, Ma Y, Anstey KJ, Banaschewski T et al (2018) Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry 23(1):133–142 (PubMed PMID: 28373689, Pubmed Central PMCID: PMC5628077) · DOI · Paper page
- Cusin C, Serretti A, Zanardi R, Lattuada E, Rossini D, Lilli R et al (2002) Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int J Neuropsychopharmacol 5(1):27–35 (PubMed PMID: 12057029) · DOI · Paper page
- de Klerk OL, Nolte IM, Bet PM, Bosker FJ, Snieder H, den Boer JA et al (2013) ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. Pharmacogenom J 13(4):349–353 (PubMed PMID: 22641028, Epub 2012/05/30.eng) · DOI
- de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6(6):463–475 (PubMed PMID: 15891777) · DOI · Paper page
- Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V et al (2008) Monoamine oxidase A variant influences antidepressant treatment response in female patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32(1):224–228 (PubMed PMID: 17884271, Epub 2007/09/22.eng) · DOI
- Dong C, Wong ML, Licinio J (2009) Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican–Americans. Mol Psychiatry 14(12):1105–1118 (PubMed PMID: 19844206, Pubmed Central PMCID: PMC2834349, Epub 2009/10/22.eng) · DOI · Paper page
- Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–457 (PubMed PMID: 20015486) · DOI · Paper page
- Dreimuller N, Tadic A, Dragicevic A, Boland K, Bondy B, Lieb K et al (2012) The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression. Pharmacopsychiatry 45(3):108–113 (PubMed PMID: 22086748, Epub 2011/11/17.eng) · doi:10.1055/s-0031-1291347
- Eichelbaum M, Fromm MF, Schwab M (2004) Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 26(2):180–185 (PubMed PMID: 15228162, Epub 2004/07/02.eng) · DOI · Paper page
- Fabbri C, Di Girolamo G, Serretti A (2013) Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. Am J Med Genet Part B Neuropsychiatr Genet 162B(6):487–520 (PubMed PMID: 23852853, Epub 2013/07/16.eng) · DOI · Paper page
- Fernandes BS, Berk M, Turck CW, Steiner J, Goncalves CA (2014) Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry 19(7):750–751 (PubMed PMID: 24342989) · DOI · Paper page
- Fiskerstrand CE, Lovejoy EA, Quinn JP (1999) An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458(2):171–174 (PubMed PMID: 10481059, Epub 1999/09/11.eng) · DOI · Paper page
- Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, Zhu W et al (2007) Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry 62(4):355–358 (PubMed PMID: 17141746, Epub 2006/12/05.eng) · DOI
- Garriock HA, Delgado P, Kling MA, Carpenter LL, Burke M, Burke WJ et al (2006) Number of risk genotypes is a risk factor for major depressive disorder: a case control study. Behav Brain Funct 2:24 (PubMed PMID: 16822313, Pubmed Central PMCID: PMC1526442, Epub 2006/07/11.eng) · DOI · Paper page
- Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD et al (2010) A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67(2):133–138 (PubMed PMID: 19846067, Epub 2009/10/23.eng) · DOI · Paper page
- Geracitano R, Federici M, Bernardi G, Mercuri NB (2006) On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons. Ann N Y Acad Sci 1074:320–329 (PubMed PMID: 17105928, Epub 2006/11/16.eng) · DOI
- Gillman PK (2007) Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151(6):737–748 (PubMed PMID: 17471183, Pubmed Central PMCID: PMC2014120, Epub 2007/05/02.eng) · DOI · Paper page
- Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test–retest reproducibility. Arch Gen Psychiatry 40(5):493–500 (PubMed PMID: 6340634, Epub 1983/05/01.eng) · DOI · Paper page
- Hahn MK, Mazei-Robison MS, Blakely RD (2005) Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 68(2):457–466 (PubMed PMID: 15894713, Epub 2005/05/17.eng) · DOI
- Hennings JM, Uhr M, Klengel T, Weber P, Putz B, Touma C et al (2015) RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Transl Psychiatry 5:e538 (PubMed PMID: 25826113, Pubmed Central PMCID: 4429173) · DOI · Paper page
- Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23(5):477–501 (PubMed PMID: 11027914) · DOI · Paper page
- Holsboer F, Ising M (2008) Central CRH system in depression and anxiety–evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol 583(2–3):350–357 (PubMed PMID: 18272149, Epub 2008/02/15.eng) · DOI · Paper page
- Hong CJ, Chen TJ, Yu YW, Tsai SJ (2006) Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenom J 6(1):27–33 (PubMed PMID: 16302021) · DOI · Paper page
- Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 78(5):815–826 (PubMed PMID: 16642437) · DOI · Paper page
- Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ et al (2007) Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 64(7):783–792 (PubMed PMID: 17606812) · DOI · Paper page
- Hwu HG, Chen TY, Yang YY (1985) The clinical diagnostic value of dexamethasone suppression test in depressive illness. Ann Acad Med Singap 14(1):104–109 (PubMed PMID: 4004115, Epub 1985/01/01.eng)
- Ide S, Kakeda S, Watanabe K, Yoshimura R, Abe O, Hayashi K et al (2015) Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: a VBM analysis of brain MRI. Psychiatry Res 233(2):120–124 (PubMed PMID: 26078197, Epub 2015/06/17. eng) · DOI
- Illi A, Setala-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N et al (2009) 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 20(12):1125–1128 (PubMed PMID: 19590397, Epub 2009/07/11.eng) · DOI · Paper page
- Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S et al (2009) A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66(9):966–975 (PubMed PMID: 19736353, Epub 2009/09/09.eng) · DOI · Paper page
- Jetten AM (2004) Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy 3(4):395–412 (PubMed PMID: 15584888) · DOI · Paper page
- Ji Y, Biernacka J, Snyder K, Drews M, Pelleymounter LL, Colby C et al (2012) Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response. Pharmacogenom J 12(1):78–85 (PubMed PMID: 20877297, Pubmed Central PMCID: PMC3113454, Epub 2010/09/30.eng) · DOI
- Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G et al (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87(2–3):305–311 (PubMed PMID: 15951024, Epub 2005/06/14.eng) · DOI · Paper page
- Kang RH, Choi MJ, Paik JW, Hahn SW, Lee MS (2007) Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression. Int J Psychiatry Med 37(3):315–329 (PubMed PMID: 18314859, Epub 2008/03/05.eng) · DOI
- Kato M, Fukuda T, Wakeno M, Fukuda K, Okugawa G, Ikenaga Y et al (2006) Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 53(4):186–195 (PubMed PMID: 16874005) · DOI · Paper page
- Kato M, Wakeno M, Okugawa G, Fukuda T, Azuma J, Kinoshita T et al (2007) No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression. Neuropsychobiology 56(4):167–171 (PubMed PMID: 18332644, Epub 2008/03/12.eng) · DOI
- Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y et al (2008) ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 32(2):398–404 (PubMed PMID: 17913323, Epub 2007/10/05.eng) · DOI · Paper page
- Kato M, Fukuda T, Wakeno M, Okugawa G, Takekita Y, Watanabe S et al (2009) Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet Part B Neuropsychiatr Genet 150B(1):115–123 (PubMed PMID: 18484082, Epub 2008/05/17.eng) · DOI · Paper page
- Katz ER, Stowe ZN, Newport DJ, Kelley ME, Pace TW, Cubells JF et al (2012) Regulation of mRNA expression encoding chaperone and co-chaperone proteins of the glucocorticoid receptor in peripheral blood: association with depressive symptoms during pregnancy. Psychol Med 42(5):943–956 (PubMed PMID: 21995950, Epub 2011/10/15.eng) · DOI
- Kautzky A, Baldinger P, Souery D, Montgomery S, Mendlewicz J, Zohar J et al (2015) The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression. Eur Neuropsychopharmacol 25(4):441–453 (PubMed PMID: 25769916, Epub 2015/03/15.eng) · DOI
- Keers R, Aitchison KJ (2010) Gender differences in antidepressant drug response. Int Rev Psychiatry (Abingdon, England) 22(5):485–500 (PubMed PMID: 21047161, Epub 2010/11/05.eng) · DOI · Paper page
- Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG et al (2000) Serotonin transporter gene polymorphism and antidepressant response. NeuroReport 11(1):215–219 (PubMed PMID: 10683861) · DOI · Paper page
- Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ et al (2006) Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296(13):1609–1618 (PubMed PMID: 17018806) · DOI · Paper page
- Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockmoller J (2007) A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenom J 7(1):48–55 (PubMed PMID: 16702979) · DOI
- Koob GF, Zorrilla EP (2012) Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology 37(1):308–309 (PubMed PMID: 22157874, Pubmed Central PMCID: PMC3238086, Epub 2011/12/14.eng) · DOI
- Kovacs D, Eszlari N, Petschner P, Pap D, Vas S, Kovacs P et al (2016) Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress. Brain Behav Immun (PubMed PMID: 26891860, Epub 2016/02/20.eng) · DOI · Paper page
- Kovacs D, Eszlari N, Petschner P, Pap D, Vas S, Kovacs P et al (2016b) Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes. J Neural Transm (Vienna, Austria: 1996) 123(5):541–548 (PubMed PMID: 26821321, Pubmed Central PMCID: PMC4846685, Epub 2016/01/29.eng) · DOI
- Kraft JB, Slager SL, McGrath PJ, Hamilton SP (2005) Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 58(5):374–381 (PubMed PMID: 15993855) · DOI · Paper page
- Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ et al (2007) Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 61(6):734–742 (PubMed PMID: 17123473) · DOI
- Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T et al (1997) Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2(6):457–462 (PubMed PMID: 9399688) · DOI · Paper page
- Laika B, Leucht S, Steimer W (2006) ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline. Clin Chem 52(5):893–895 (PubMed PMID: 16638956) · DOI · Paper page
- Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004) Association of the C(−1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 7(4):501–506 (PubMed PMID: 15447813) · DOI · Paper page
- Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531 (PubMed PMID: 8929413) · DOI · Paper page
- Licinio J, O’Kirwan F, Irizarry K, Merriman B, Thakur S, Jepson R et al (2004) Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican–Americans. Mol Psychiatry 9(12):1075–1082 (PubMed PMID: 15365580) · DOI · Paper page
- Lifschytz T, Gur E, Lerer B, Newman ME (2004) Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140(1–2):133–139 (PubMed PMID: 15589343, Epub 2004/12/14.eng) · DOI
- Lin JY, Jiang MY, Kan ZM, Chu Y (2014) Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis. J Affect Disord 168:430–438 (PubMed PMID: 25108775) · DOI
- Lisiecka DM, O’Hanlon E, Fagan AJ, Carballedo A, Morris D, Suckling J et al (2015) BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls. J Affect Disord 184:239–244 (PubMed PMID: 26117067, Epub 2015/06/29.eng) · DOI
- Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al (2005) Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s disease. Am J Med Genet Part B Neuropsychiatr Genet 134B(1):93–103 (PubMed PMID: 15666411, Epub 2005/01/25.eng) · DOI · Paper page
- Lopizzo N, Tosato S, Begni V, Tomassi S, Cattane N, Barcella M et al (2017) Transcriptomic analyses and leukocyte telomere length measurement in subjects exposed to severe recent stressful life events. Transl Psychiatry 7(2):e1042 (PubMed PMID: 28221367, Pubmed Central PMCID: PMC5438034) · DOI
- MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96(26):15251–15255 (PubMed PMID: 10611371, Pubmed Central PMCID: PMC24806, Epub 1999/12/28.eng) · DOI · Paper page
- Mandelli L, Mazza M, Martinotti G, Tavian D, Colombo E, Missaglia S et al (2010) Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J Psychopharmacol (Oxford, England) 24(12):1747–1754 (PubMed PMID: 20142305, Epub 2010/02/10. eng) · DOI
- Maron E, Tammiste A, Kallassalu K, Eller T, Vasar V, Nutt DJ et al (2009) Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. Eur Neuropsychopharmacol 19(6):451–456 (PubMed PMID: 19272758, Epub 2009/03/11.eng) · DOI
- Min W, Li T, Ma X, Li Z, Yu T, Gao D et al (2009) Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Psychopharmacology 205(3):409–417 (PubMed PMID: 19468717, Epub 2009/05/27.eng) · DOI
- Murphy DL, Lerner A, Rudnick G, Lesch KP (2004a) Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4(2):109–123 (PubMed PMID: 15087484, Epub 2004/04/17.eng) · DOI · Paper page
- Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004b) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61(11):1163–1169 (PubMed PMID: 15520364) · DOI · Paper page
- Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E (2007) Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry 61(2):167–173 (PubMed PMID: 16697352, Epub 2006/05/16.eng) · DOI
- Nakamura K, Hasegawa H (2007) Developmental role of tryptophan hydroxylase in the nervous system. Mol Neurobiol 35(1):45–54 (PubMed PMID: 17519505, Epub 2007/05/24.eng) · DOI
- Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997) Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45(1):145–148 (PubMed PMID: 9105682, Epub 1997/04/01.eng) · DOI · Paper page
- Niitsu T, Fabbri C, Bentini F, Serretti A (2013) Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 1(45):183–194 (PubMed PMID: 23733030) · DOI · Paper page
- Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM et al (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet (London, England) 347(9003):731–733 (PubMed PMID: 8602004, Epub 1996/03/16.eng) · DOI · Paper page
- Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J et al (2012) Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Transl Psychiatry 2:e101 (PubMed PMID: 22832901, Epub 2012/07/27.eng) · DOI · Paper page
- Pandey DK, Mahesh R, Kumar AA, Rao VS, Arjun M, Rajkumar R (2010a) A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacol Biochem Behav 94(3):363–373 (PubMed PMID: 19800913, Epub 2009/10/06.eng) · DOI
- Papiol S, Arias B, Gasto C, Gutierrez B, Catalan R, Fananas L (2007) Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. J Affect Disord 104(1–3):83–90 (PubMed PMID: 17467808, Epub 2007/05/01.eng) · DOI · Paper page
- Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ (2006) Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31(8):1745–1749 (PubMed PMID: 16395308, Epub 2006/01/06.eng) · DOI · Paper page
- Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM et al (2003) Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 54(9):879–883 (PubMed PMID: 14573314) · DOI · Paper page
- Perlis RH, Fijal B, Dharia S, Heinloth AN, Houston JP (2010) Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients. Biol Psychiatry 67(11):1110–1113 (PubMed PMID: 20110084, Epub 2010/01/30.eng) · DOI
- Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP (2004) Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 9(9):879–889 (PubMed PMID: 15052272) · DOI · Paper page
- Peters EJ, Slager SL, Kraft JB, Jenkins GD, Reinalda MS, McGrath PJ et al (2008) Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PloS One 3(4):e1872 (PubMed PMID: 18382661, Pubmed Central PMCID: PMC2268970, Epub 2008/04/03.eng) · DOI · Paper page
- Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H et al (2010) Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 13(4):535–539 (PubMed PMID: 19941699) · DOI · Paper page
- Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A (2011) Pharmacogenetics of antidepressant response. J Psychiatry Neurosci 36(2):87–113 (PubMed PMID: 21172166, Pubmed Central PMCID: PMC3044192, Epub 2010/12/22.eng) · DOI · Paper page
- Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T et al (2013) Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. Eur Neuropsychopharmacol 23(9):1105–1114 (PubMed PMID: 23142150, Epub 2012/11/13.eng) · DOI
- Ray A, Tennakoon L, Keller J, Sarginson JE, Ryan HS, Murphy GM et al (2015) ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. Pharmacogenom J 15(4):332–339 (PubMed PMID: 25487678, Epub 2014/12/10.eng) · DOI
- Ruhe HG, Ooteman W, Booij J, Michel MC, Moeton M, Baas F et al (2009) Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder. Pharmacogenet Genom 19(1):67–76 (PubMed PMID: 18987562, Epub 2008/11/07.eng) · DOI · Paper page
- Sarginson JE, Lazzeroni LC, Ryan HS, Ershoff BD, Schatzberg AF, Murphy GM Jr (2010) ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenet Genom 20(8):467–475 (PubMed PMID: 20555295, Epub 2010/06/18.eng) · DOI · Paper page
- Sartorius N (2001) The economic and social burden of depression. J Clin Psychiatry 62(Suppl 15):8–11 (PubMed PMID: 11444765, Epub 2001/07/11.eng)
- Schatzberg AF, DeBattista C, Lazzeroni LC, Etkin A, Murphy GM Jr, Williams LM (2015) ABCB1 genetic effects on antidepressant outcomes: a report from the iSPOT-D trial. Am J Psychiatry 172(8):751–759 (PubMed PMID: 25815420, Epub 2015/03/31.eng) · DOI · Paper page
- Serretti A, Artioli P (2004) The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenom J 4(4):233–244 (PubMed PMID: 15111987, Epub 2004/04/28.eng) · DOI
- Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E (2001) Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol 11(5):375–380 (PubMed PMID: 11597824) · DOI
- Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R (2004) The C(−1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 7(4):453–460 (PubMed PMID: 15458611) · DOI · Paper page
- Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217 (PubMed PMID: 10202537, Pubmed Central PMCID: PMC2844879, Epub 1999/04/15.eng) · DOI · Paper page
- Shiroma PR, Drews MS, Geske JR, Mrazek DA (2014) SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a sequenced treatment alternatives to relieve depression (STAR*D) report. Am J Geriatr Psychiatry 22(11):1140–1148 (PubMed PMID: 23973251, Pubmed Central PMCID: PMC4358736, Epub 2013/08/27.eng) · DOI
- Smith AJ, Sketris I, Cooke C, Gardner D, Kisely S, Tett SE (2008) A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf 17(7):697–706 (PubMed PMID: 18181227, Epub 2008/01/09.eng) · DOI
- Smits K, Smits L, Peeters F, Schouten J, Janssen R, Smeets H et al (2007) Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 22(3):137–143 (PubMed PMID: 17414739, Epub 2007/04/07.eng) · DOI · Paper page
- Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E (2011) An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J Affect Disord 128(1–2):41–48 (PubMed PMID: 20619899, Epub 2010/07/14.eng) · DOI
- Spurlock G, Heils A, Holmans P, Williams J, D’Souza UM, Cardno A et al (1998) A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 3(1):42–49 (PubMed PMID: 9491812, Epub 1998/03/10.eng) · DOI · Paper page
- Suzuki Y, Sawamura K, Someya T (2004) The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients. Pharmacogenom J 4(4):283–286 (PubMed PMID: 15148501) · DOI
- Szegedi A, Rujescu D, Tadic A, Muller MJ, Kohnen R, Stassen HH et al (2005) The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenom J 5(1):49–53 (PubMed PMID: 15520843) · DOI
- Tadic A, Muller MJ, Rujescu D, Kohnen R, Stassen HH, Dahmen N et al (2007) The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet Part B Neuropsychiatr Genet 144B(3):325–331 (PubMed PMID: 17192957, Epub 2006/12/29.eng) · DOI · Paper page
- Tsai SJ, Hong CJ, Chen TJ, Yu YW (2007) Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment. Am J Med Genet B Neuropsychiatr Genet 144(8):1097–1098 (PubMed PMID: 17721930, Epub 2007/08/28.eng) · DOI
- Udina M, Moreno-Espana J, Navines R, Gimenez D, Langohr K, Gratacos M et al (2013) Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 38(9):1803–1813 (PubMed PMID: 23571152, Epub 2013/04/11.eng) · DOI
- Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W et al (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167(5):555–564 (PubMed PMID: 20360315, Epub 2010/04/03.eng) · DOI · Paper page
- Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J et al (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171(12):1278–1286 (PubMed PMID: 25017001) · DOI · Paper page
- Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M et al (2008) Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57(2):203–209 (PubMed PMID: 18215618, Epub 2008/01/25.eng) · DOI · Paper page
- van Rossum EF, Binder EB, Majer M, Koper JW, Ising M, Modell S et al (2006) Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry 59(8):681–688 (PubMed PMID: 16580345) · DOI · Paper page
- Villafuerte SM, Vallabhaneni K, Sliwerska E, McMahon FJ, Young EA, Burmeister M (2009) SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A. Psychiatr Genet 19(6):281–291 (PubMed PMID: 19829169, Pubmed Central PMCID: PMC2783179, Epub 2009/10/16.eng) · DOI · Paper page
- Wang HC, Yeh TL, Chang HH, Gean PW, Chi MH, Yang YK et al (2011) TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology 213(4):773–779 (PubMed PMID: 20945066, Epub 2010/10/15.eng) · DOI
- Wang Y, Liu X, Yu Y, Han Y, Wei J, Collier D et al (2012) The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment. Psychiatry Res 200(2–3):1047–1050 (PubMed PMID: 22796099, Epub 2012/07/17.eng) · DOI
- Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K et al (2004) Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 161(9):1575–1580 (PubMed PMID: 15337646) · DOI · Paper page
- Yoshida K, Higuchi H, Takahashi H, Kamata M, Sato K, Inoue K et al (2008) Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran. Hum Psychopharmacol 23(2):121–128 (PubMed PMID: 18023073, Epub 2007/11/21.eng) · DOI · Paper page
- Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ (2006) Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 16(7):498–503 (PubMed PMID: 16458487) · DOI
- Zakharyan R, Petrek M, Arakelyan A, Mrazek F, Atshemyan S, Boyajyan A (2012) Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. Tissue Antigens 80(2):136–142 (PubMed PMID: 22571276, Epub 2012/05/11.eng) · DOI
- Zhao X, Huang Y, Li J, Ma H, Jin Q, Wang Y et al (2012) Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis. Int Clin Psychopharmacol 27(6):314–320 (PubMed PMID: 22890315, Epub 2012/08/15.eng)
- Zorrilla EP, Heilig M, de Wit H, Shaham Y (2013) Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128(3):175–186 (PubMed PMID: 23294766, Pubmed Central PMCID: PMC3596012, Epub 2013/01/09.eng) · DOI · Paper page
- Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH et al (2010) Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61(2):71–78 (PubMed PMID: 20016225, Epub 2009/12/18.eng) · DOI · Paper page
Cited by
Zelada, M. I., Garrido, V., Liberona, A., Jones, N., Zúñiga, K., Silva, H., & Nieto, R. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914810 · Cited by 60
Menke, A. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s146110 · Cited by 41
Self-citationMoving pharmacoepigenetics tools for depression toward clinical use
Hack, L. M., Fries, G. R., Eyre, H. A., Bousman, C. A., Singh, A. B., Quevedo, J., John, V. P., Baune, B. T., & Dunlop, B. W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.009 · Cited by 33
Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
von Zimmermann, C., Böhm, L., Richter-Schmidinger, T., Kornhuber, J., Lenz, B., & Mühle, C. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-020-02288-7 · Cited by 13
Metadata
- Authors
- Busch, Y., & Menke, A.
- Venue
- Journal of Neural Transmission
- Published
- 2018-01-27
- Volume
- 126
- Issue
- 1
- Pages
- 47-63
- ISSN
- 0300-9564
- 1435-1463
- Cited by
- 27
- References
- 57
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood-based biomarkers predicting response to antidepressants. https://app.cochat.ai/papers/10.1007/s00702-018-1844-x
- The paper
- Busch, Y., & Menke, A. (2019). Blood-based biomarkers predicting response to antidepressants. Journal of Neural Transmission. https://doi.org/10.1007/s00702-018-1844-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.